Search by Drug Name or NDC

    NDC 36800-0744-62 topcare all day allergy d 5; 120 mg/1; mg/1 Details

    topcare all day allergy d 5; 120 mg/1; mg/1

    topcare all day allergy d is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Topco Associates LLC. The primary component is CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 36800-0744
    Product ID 36800-744_31cdaa1a-0e89-4c41-a0d1-1ac57ed040dc
    Associated GPIs 43993002277420
    GCN Sequence Number 048415
    GCN Sequence Number Description cetirizine HCl/pseudoephedrine TAB ER 12H 5 MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 13866
    HICL Sequence Number 022864
    HICL Sequence Number Description CETIRIZINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name topcare all day allergy d
    Proprietary Name Suffix n/a
    Non-Proprietary Name cetirizine hydrochloride, pseudoephedrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Topco Associates LLC
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210719
    Listing Certified Through 2024-12-31

    Package

    NDC 36800-0744-62 (36800074462)

    NDC Package Code 36800-744-62
    Billing NDC 36800074462
    Package 24 BLISTER PACK in 1 CARTON (36800-744-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2020-03-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 103df878-1455-414f-94cb-5b32a2d3e4b8 Details

    Revised: 2/2022